Native and modified LDL activate extracellular signal-regulated kinases in mesangial cells

Diabetes

Volumn 49, Issue 12, 2000, Pages 2160-2169

  Jenkins, Alicia J ^a   Velarde, Victoria ^a   Klein, Richard L ^b   Joyce, Kevin C ^a   Phillips, K Dan ^a   Mayfield, Ronald K ^a   Lyons, Timothy J ^a   Jaffa, Ayad A ^a,c  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; LOW DENSITY LIPOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CELL FUNCTION; CONCENTRATION RESPONSE; DIABETIC NEPHROPATHY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GLYCATION; HUMAN; HUMAN CELL; MESANGIUM CELL; MITOGENESIS; NONHUMAN; OXIDATION; PRIORITY JOURNAL; RAT;

EID: 0033645682     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.49.12.2160     Document Type: Article

References (59)

1. Structure functional relationships in diabetic nephropathy
2. Lipoproteins and atherosclerosis: Lipoprotein metabolism
3. Analogous pathobiologic mechanisms in glomerulosclerosis and atherosclerosis
4. Cellular mechanisms of lipid injury in the glomerulus
5. The role of lipids in nephrosclerosis and glomerulosclerosis
6. Beyond cholesterol
7. Stimulation of cholesteryl ester synthesis in human monocyte-derived macrophages by lipoproteins from type I diabetic subjects: The influence of non-enzymatic glycosylation of low-density lipoproteins
8. Glycated lipoproteins
9. Oxidized lipoproteins, altered cell function and atherosclerosis
10. Glycation and oxidation: A role in the pathogenesis of atherosclerosis
11. Toxicity of mildly modified low-density lipoproteins to cultured retinal capillary endothelial cells and pericytes
12. Role of glycated low density lipoprotein in mesangial extracellular matrix synthesis
13. Glycation of low density lipoprotein in patients with type 1 diabetes: Correlations with other parameters of glycemic control
14. Reduced plasma peroxyl radical trapping capacity and increased susceptibility of LDL to oxidation in poorly controlled IDDM
15. Glycosylated LDL is more sensitive to oxidation: Implications for the diabetic patient?
16. The role of cholesterol in glomerular injury
17. Effects of low-density lipoproteins on mesangial cell growth and viability in vitro
18. Oxidation of low density lipoprotein by mesangial cells may promote glomerular injury
19. Oxidized LDL in experimental focal glomerulosclerosis
20. Oxidation of LDLs by rat mesangial cells and the interaction of oxidized LDLs with rat mesangial cells in vitro
21. Interactions of LDL and modified LDL with mesangial cells and matrix
22. Preferential binding of oxidized LDL to rat glomeruli in vivo and cultured mesangial cells in vitro
23. Effects of glycated albumin on mesangial cells: Evidence for a role in diabetic nephropathy
24. Amadori glucose adducts modulate mesangial cell growth and collagen gene expression
25. Advanced glycosylation in nephropathy of diabetes and aging
26. Effect of modified low-density lipoprotein cholesterol and α-tocopherol on mesangial cell viability
27. Modified lipoproteins induce mitogen-activated protein kinase (MAPK) activity and TGF-β expression in mesangial cells
28. The emerging role of transforming growth factor β in kidney diseases
29. Oxidized LDL stimulates the expression of TGF-β and fibronectin in human glomerular epithelial cells
30. Contrary effects of lightly and strongly oxidized LDL with potent promotion of growth versus apoptosis on arterial smooth muscle cells, macrophages, and fibroblasts
31. Stimulation of mitogen activated protein kinase by LDL and ox-LDL in human U-937 macrophage-like cells
32. Oxidized LDL stimulates mitogen-activated protein kinases in smooth muscle cells and macrophages
33. Cell signal transduction through the mitogen activated protein kinase pathway
34. Atherogenic lipoproteins stimulate mesangial cell p42 mitogen activated protein kinase
35. Stretch-induced overproduction of fibronectin in mesangial cells is mediated by the activation of mitogen-activated protein kinase
36. Oxidized low density lipoprotein induces apoptosis in cultured human umbilical vein endothelial cells by common and unique mechanisms
37. Mitogen-activated protein kinases as glucose transducers for diabetic complications
38. PKC activatiion and its role in the development of vascular complications in diabetes mellitus
39. PKC activation and the development of diabetic complications
40. Pre-enrichment of modified low density lipoproteins with α-tocopherol mitigated adverse effects on cultured retinal capillary cells
41. Aminoguanidine and the toxicity of modified LDL to cultured retinal capillary cells
42. Effect of modified low density lipoprotein cholesterol and α-tocopherol on mesangial cell viability
43. Neutral proteinase activity produced in vitro by cells of glomerular mesangium
44. Isolation, characterization, and metabolism of the glycated and non-glycated subfractions of low-density lipoproteins isolated from type 1 diabetic patients and nondiabetic subjects
45. Protein measurement with the folin phenol reagent
46. The growth-promoting effect of low-density lipoprotein may be mediated by a pertussis toxin-sensitive mitogen activated protein kinase pathway
47. FLIPR: A new instrument for accurate, high throughput optical screening
48. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples
49. Calcium-calmodulin mediates bradykinin-induced MAPK phosphorylation and c-fos induction in vascular cells
50. Characterisation of protein kinase C β isoform activation on the gene expression of transforming growth factor β, extracellular matrix components and prostanoids in the glomeruli of diabetic rats
51. Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated pathway regulated by oxidant stress
52. Advanced glycation endproducts stimulate the MAP-kinase pathway in tubulus cell line LLC-PK 1
53. Cell activation by glycated proteins: AGE receptors, receptor recognition factors and functional classification of AGEs
54. Active oxygen species and lysophosphatidylcholine are involved in oxidized low density lipoprotein activation of smooth muscle cell DNA synthesis
55. ++] in cultured rat mesangial cells
56. Adenosine, deoxyadenosine, and deoxyguanasine induce DNA cleavage in mouse thymocytes
57. Apolipoproteins and lipoprotein receptors in glomeruli in human kidney diseases
58. Expression of receptors for advanced glycosylated end-products in renal disease